NCT00354874View on ClinicalTrials.gov

Investigation Of A New Medication (GW642444) In Asthmatic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Asthma
Interventions
DRUG

GW642444

drug

DRUG

Placebo

placebo

DRUG

salmeterol 50mcg

salmeterol

Trial Locations (3)

22927

GSK Investigational Site, Großhansdorf

65187

GSK Investigational Site, Wiesbaden

SE-413 45

GSK Investigational Site, Gothenburg

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY